Reuters logo
BRIEF-Taro pharmaceutical industries Q4 shr $2.68
May 26, 2016 / 11:42 PM / a year ago

BRIEF-Taro pharmaceutical industries Q4 shr $2.68

May 26 (Reuters) - Taro Pharmaceutical Industries Ltd :

* Qtrly net sales of $265.1 million, increased $20.9 million, or 8.6%, on relatively flat volumes

* Taro provides results for year ended march 31, 2016

* Q4 earnings per share $2.68

* Q4 sales rose 8.6 percent to $265.1 million

Source text for Eikon:

Further company coverage: (Bengaluru Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below